In more than two decades of empirical research into cancer, abnormal DAPK promoter methylation has been reported in more than 30 types of human cancers due to impaired expression of DAPK, including breast, leukemia, and lung cancers, although the status of methylation significantly differs from type to type.119, 121. This evidence concerns the gene DAPK1 and lung carcinoma.